83P Cerebral Toxicity of Whole Brain Radiotherapy Plus Icotinib in Rats
L. Zhou,R. Li,F. Tang,J. Liu,R. Tong,J. Xue,Y. Liu,S. Wang,R. Zhong,Y. Lu
DOI: https://doi.org/10.1016/s1556-0864(16)30196-4
IF: 20.121
2016-01-01
Journal of Thoracic Oncology
Abstract:Whole-brain radiation therapy (WBRT) and epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) are both treatment options for EGFR-mutated NSCLC patients with brain metastases. This study aimed to investigate the possible cerebral toxicities caused by the combined treatment in rats. Thirty-six, 12 weeks old, male, SD rats were randomized into 6 groups (6 rats in each group named A to F). Rats in group A and B received high dose (101.25mg/kg qd) or low dose (33.75 mg/kg qd) icotinib (one kind of EGFR-TKIs) plus WBRT, group C and D received high dose or low dose icotinib only, group E received WBRT only, and group F was the sham control group. Icotinib was administered intragastrically once daily from day 1 and WBRT (30 Gy/5f/5d) was carried out 2 weeks later. All rats received Morris water maze test, including place navigation test and spatial probe test, at baseline, 4th week, 8th week, and 12th week to investigate their learning and memory abilities. All rates were sacrificed after the last water maze test, and the number of positive cells of GFAP (astrocyte), CD11b (microglia), and CNPase (oligodendrocyte) were evaluated in immunohistochemical samples from Hippocampus. There were no difference in the target finding latency and journey distance in place navigation tests between different groups and time points, neither in the percentage of stay time and journey distance of the target quadrant to total in spatial probing tests. Compare to group F, significantly more GFAP+ astrocytes could be observed in treatment groups (Group A to F: 87.4±15.8 vs. 92.8±28 vs. 91.7±14.4 vs. 92±19.6 vs. 87.6±16.6 vs. 64.8±24.4, p < 0.001). Compare to other groups, significantly more CD11b+ microglias could be observed in groups received WBRT (Group A to F: 54.5±14.8 vs. 47.7±15.4 vs. 38.6±15 vs. 36.7±19 vs. 58.1±18.1 vs. 35.2±24.2, p < 0.001; Group A+B+E, C+D, and F: 52.6±22.2 vs. 36.1±17.9 vs. 33.1±24.5, p < 0.001). There was no significant difference in number of CNPase+ oligodendrocytes between different groups. In rats, even there was no deterioration in cognitive function detected by water maze tests, pathological changes in hippocampus could be detected within a relatively short period after the combined treatment or icotinib treatment alone.